MZEI – Firm Foundation and Excellent Forward Momentum
Parsing the June 15th Press Release
The press release of Monday, June 15, 2009, was loaded with information. We have already examined the incredible news that Medizone will provide the most secure reduction in Pseudomonas aeruginousa and ain Methicillin Resistant Staph Aureus (MRSA) available. Actually, at levels not previously envisioned to be acheivable.
This was round TWO and a THIRD technological development IS STILL TO BE INTRODUCED IN THIS SERIES OF TRIALS.
AsepticSure(TM) has the technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. If current trials continue to proceed successfully they will be followed by a hospital mock-up and then hospital beta testing of the production prototype.
MEDIZONE ACTUALLY STATED IN THEIR PRESS RELEASE THIS TECHNOLOGY WILL SAVE HUNDREDS OF THOUSANDS OF LIVES EACH YEAR — WORLDWIDE. THIS IS NEWS TO BE ACCEPTED CAREFULLY AND WITH FULL CONSIDERATION. If you were a hospital administrator — with your DIRTY LITTLE SECRET OUT IN THE WORLD FRONT AND CENTER — WITH PLAINTIFF’S ATTORNEYS LICKING THEIR CHOPS AND WITH STATE LEGISTLATURES DEMANDING ACCOUNTABLITY — would you even begin to say — NO, LET’S GO WITH THE LESS EFFECTIVE PRODUCT?
How could any responsible hospital administrator not chose the most effective sterilization product on the market? AND Medizone has the laboratory testing to prove their position.
This is a great sales pitch but it is so much more than that — this is a product this world truly, truly needs. These are long, excrutiating deaths. Lives are lost needlessly.
Medizone can help solve this problem. Initial sales are targeted to commence in the 4th quarter of this year.
Contact:
Medizone International, Inc. (OTC: MZEI)
144 Buena Vista
P.O. Box 742
Stinson Beach, CA 94970
Web: http://www.medizoneint.com
Telephone: 415-868-0300
Fax: 415-868-2344
Investor Relations 800-953-3350
E-mail: operations@medizoneint.com
Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 200,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This blog contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to,the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.
